| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 678343 | Null | 0.00970780973624031 | 0.36920773 |
| NSC 683140 | Null | 0.00970780973624031 | 0.53208008 |
| NSC 689531 | Hydrazinecarbothioamide, 2-[(2-pyridinyl)phenylmethylene]-N-[2-(2-pyridinyl)ethyl]- | 0.00970780973624031 | 0.28875086 |
| NSC 691276 | Null | 0.00970780973624031 | 0.42670701 |
| NSC 692579 | Null | 0.00970780973624031 | 0.48565065 |
| NSC 701383 | Null | 0.00970780973624031 | 0.57316817 |
| NSC 720299 | Methyl-7.alpha.,12.alpha.-diacetoxy-5.beta.-cholan-24-oate-~ 3-spiro-6'-(1',2',4',5'-tetraoxacyclohexane)-3'-spirocyclo pentane | 0.00970780973624031 | 0.42752288 |
| NSC 723732 | 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one | 0.00970780973624031 | 0.26071324 |
| NSC 730868 | (+)-(2R,3R)-6-{4-[(3-hydroxymethyl)oxiran-2-yl]buta-1,3-diyn yl}-2H-pyran-2-one | 0.00970780973624031 | 0.43399646 |
| NSC 735030 | Null | 0.00970780973624031 | 0.38624908 |